Yonathan Brhane
Yonathan Brhane
Verified email at
Cited by
Cited by
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ...
Nature genetics 49 (7), 1126-1132, 2017
Cannabis smoking and lung cancer risk: Pooled analysis in the I nternational L ung C ancer C onsortium
LR Zhang, H Morgenstern, S Greenland, SC Chang, P Lazarus, MD Teare, ...
International journal of cancer 136 (4), 894-903, 2015
A cross-cancer genetic association analysis of the DNA repair and DNA damage signaling pathways for lung, ovary, prostate, breast, and colorectal cancer
PM Scarbrough, RP Weber, ES Iversen, Y Brhane, CI Amos, P Kraft, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (1), 193-200, 2016
Cross cancer genomic investigation of inflammation pathway for five common cancers: lung, ovary, prostate, breast, and colorectal cancer
RJ Hung, CM Ulrich, EL Goode, Y Brhane, K Muir, AT Chan, LL Marchand, ...
Journal of the National Cancer Institute 107 (11), djv246, 2015
Identification of susceptibility pathways for the role of chromosome 15q25. 1 in modifying lung cancer risk
X Ji, Y Bossé, MT Landi, J Gui, X Xiao, D Qian, P Joubert, M Lamontagne, ...
Nature Communications 9 (1), 3221, 2018
Genome-wide association study of familial lung cancer
J Byun, AG Schwartz, C Lusk, AS Wenzlaff, M De Andrade, D Mandal, ...
Carcinogenesis 39 (9), 1135-1140, 2018
A novel genetic variant in long non-coding RNA gene NEXN-AS1 is associated with risk of lung cancer
H Yuan, H Liu, Z Liu, K Owzar, Y Han, L Su, Y Wei, RJ Hung, ...
Scientific reports 6 (1), 1-8, 2016
Assessing lung cancer absolute risk trajectory based on a polygenic risk model
RJ Hung, MT Warkentin, Y Brhane, N Chatterjee, DC Christiani, MT Landi, ...
Cancer research 81 (6), 1607-1615, 2021
Lung cancer risk in never-smokers of European descent is associated with genetic variation in the 5p15. 33 TERT-CLPTM1Ll region
RJ Hung, MR Spitz, RS Houlston, AG Schwartz, JK Field, J Ying, Y Li, ...
Journal of Thoracic Oncology 14 (8), 1360-1369, 2019
Protein-altering germline mutations implicate novel genes related to lung cancer development
X Ji, S Mukherjee, MT Landi, Y Bosse, P Joubert, D Zhu, I Gorlov, X Xiao, ...
Nature communications 11 (1), 2220, 2020
Elevated platelet count appears to be causally associated with increased risk of lung cancer: A mendelian randomization analysis
Y Zhu, Y Wei, R Zhang, X Dong, S Shen, Y Zhao, J Bai, D Albanes, ...
Cancer Epidemiology, Biomarkers & Prevention 28 (5), 935-942, 2019
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
L Kachuri, M Johansson, SR Rashkin, RE Graff, Y Bossé, V Manem, ...
Nature communications 11 (1), 27, 2020
Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma
J Teichman, L Dodbiba, H Thai, A Fleet, T Morey, L Liu, M McGregor, ...
PLoS One 13 (5), e0194809, 2018
Functional variants in DCAF4 associated with lung cancer risk in European populations
H Liu, Z Liu, Y Wang, TE Stinchcombe, K Owzar, Y Han, RJ Hung, ...
Carcinogenesis 38 (5), 541-551, 2017
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein …
DC Qian, J Byun, Y Han, CS Greene, JK Field, RJ Hung, Y Brhane, ...
Human molecular genetics 24 (25), 7406-7420, 2015
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma
I Pasic, KM Wong, JJ Lee, O Espin‐Garcia, Y Brhane, D Cheng, Z Chen, ...
Molecular Carcinogenesis 57 (1), 106-113, 2018
Pathway‐analysis of published genome‐wide association studies of lung cancer: A potential role for the CYP4F3 locus
J Yin, H Liu, Z Liu, K Owzar, Y Han, L Su, Y Wei, RJ Hung, Y Brhane, ...
Molecular carcinogenesis 56 (6), 1663-1672, 2017
Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs
Y Pan, H Liu, Y Wang, X Kang, Z Liu, K Owzar, Y Han, L Su, Y Wei, ...
Scientific reports 7 (1), 1-8, 2017
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia
DR Brenner, CI Amos, Y Brhane, MN Timofeeva, N Caporaso, Y Wang, ...
Carcinogenesis 36 (11), 1314-1326, 2015
BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR. 24 TrialBRM Polymorphisms and Lung Cancer …
G Liu, S Cuffe, S Liang, AK Azad, L Cheng, Y Brhane, X Qiu, DW Cescon, ...
Clinical Cancer Research 23 (10), 2460-2470, 2017
The system can't perform the operation now. Try again later.
Articles 1–20